Mr Bourla does not say in the interview that COVID jabs are dangerous. The interview begins at the 35 seconds mark of the ...
The stock has spent the past few years in the shadow of a COVID-19 boost, but it's time investors see the light.
Pfizer said it will 'support capacity-building initiatives, such as training healthcare professionals and advancing clinical ...
Pfizer Inc. closed 16.17% below its 52-week high of $31.54, which the company achieved on July 30th.
Oklahoma City Indian Clinic announced it has received a $250,000 charitable contribution from Pfizer to support programs ...
At the JPM conference, Pfizer CEO Albert Bourla projected optimism, saying the market was overlooking the pharma company's ...
U.S. drugmaker Pfizer is going "all in" to develop its experimental obesity drug and has been recruiting more experts in that ...
The general mood among these heavyweight investors is divided, with 33% leaning bullish and 50% bearish. Among these notable ...
The sale decreases Pfizer’s shareholding in the consumer-healthcare business to 7.3% of its issued share capital, down from ...
We recently compiled a list of the 15 Stocks to Invest in with Steady Dividends. In this article, we are going to take a look ...